• 4790 Citations
  • 15 h-Index
19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where E. Hitre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 4790 Citations
  • 15 h-Index
  • 40 Article
  • 4 Review article
  • 1 Comment/debate

Final analysis of the prevention of early menopause study (POEMS)/SWOG intergroup S0230

Moore, H. C. F., Unger, J. M., Phillips, K. A., Boyle, F., Hitre, E., Moseley, A., Porter, D. J., Francis, P. A., Goldstein, L. J., Gomez, H. L., Vallejos, C. S., Partridge, A. H., Dakhil, S. R., Garcia, A. A., Gralow, J. R., Lombard, J. M., Forbes, J. F., Martino, S., Barlow, W. E., Fabian, C. J. & 5 others, Minasian, L. M., Meyskens, F. L., Gelber, R. D., Hortobagyi, G. N. & Albain, K. S., 2019, In : Journal of the National Cancer Institute. 111, 2, p. 210-213 4 p.

Research output: Contribution to journalArticle

  • 13 Citations (Scopus)

    Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer

    Rubovszky, G., Budai, B., Ganofszky, E., Horváth, Z., Juhos, É., Madaras, B., Nagy, T., Szabó, E., Pintér, T., Tóth, E., Nagy, P., Láng, I. & Hitre, E., Apr 1 2018, In : Pathology and Oncology Research. 24, 2, p. 237-244 8 p.

    Research output: Contribution to journalArticle

  • 4 Citations (Scopus)

    Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study

    Kószó, R., Sántha, D., Büdi, L., Erfán, J., Győrfy, K., Horváth, Z., Kocsis, J., Landherr, L., Hitre, E., Máhr, K., Pajkos, G., Pápai, Z. & Kahán, Z., Jul 1 2017, In : Pathology and Oncology Research. 23, 3, p. 505-511 7 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)